CompanyOTCVancouver, WA

CytoDyn Inc

SEC EDGAR ClinicalTrials.gov

10-QOct 29Latest SEC filing, period to Sep 30

Form DMay 11$19M sold

October 2026

CytoDyn names Robert Hoffman CEO, moves Lalezari to research role

Oct 19PeopleCytoDyn Inc TuHURA Biosciences, Inc